Thomas J. Polascik, MD

Articles by Thomas J. Polascik, MD

Prostate Cancer Focal Therapy Has Made Great Strides and the Future Remains Bright

May 14th 2021

Thomas J. Polascik, MD, reflects on a manuscript written by his colleagues regarding the use of focal therapy to treat localized prostate cancer.

Low-Risk and Very-Low-Risk Prostate Cancer: Is There a Role for Focal Therapy in the Era of Active Surveillance? Yes, the Two Approaches Complement Each Other

ByLaurence Klotz, MD, FRCSC, CM,Thomas J. Polascik, MD

November 15th 2014

Investigators and physicians caring for the spectrum of prostate cancer should have a targeted treatment option available for patients who would benefit by it.

Thomas J. Polascik, MD

Articles by Thomas J. Polascik, MD

Prostate Cancer Focal Therapy Has Made Great Strides and the Future Remains Bright

Low-Risk and Very-Low-Risk Prostate Cancer: Is There a Role for Focal Therapy in the Era of Active Surveillance? Yes, the Two Approaches Complement Each Other

Latest Updated Articles

Trending on CancerNetwork

Sigvotatug Vedotin Does Not Significantly Improve Survival in NSCLC Trial

Cellular Therapy and Antibody-Drug Conjugates Shape Day 1 of ASCO Breakthrough 2026

AI and MRD Take Center Stage on Day 2 of ASCO Breakthrough 2026

GLP-1 Receptor Agonists Reduce Colorectal Cancer Risk in IBD Populations

NCCN Updates Bladder Cancer Guidelines for ctDNA MRD Testing